<DOC>
	<DOCNO>NCT00273650</DOCNO>
	<brief_summary>We test specific dietary supplement , methylcobalamin ( vitamin B12 ) . Follow-up assessment clinical team take place 12-week study period record change development . The main goal study determine subcutaneous injection vitamin B12 give every three day positively affect behavior development child autism . Hypothesis : Methylcobalamin injection improve measure executive function , speech , socialization child autism , associate metabolic improvement .</brief_summary>
	<brief_title>Efficacy Study Subcutaneous Methyl-B12 Children With Autism</brief_title>
	<detailed_description>Autism complex neurodevelopmental disorder think involve interaction multiple variable susceptibility gene ( Keller &amp; Persico , 2003 ) , epigenetic effect ( Beaudet , 2002 ) , environmental factor ( London , 2000 ) . The increase prevalence autistic spectrum disorder 4-5/10,000 1980s 30-60/10,000 last decade raise great concern ( Bertrand et al. , 2001 ; DeStefano et al. , 2004 ; Steinhausen et al. , 1986 ; Yeargin-Allsopp et al. , 2003 ) . Research potential therapeutic intervention design ameliorate metabolic clinical symptom autism urgently need reduce enormous public health burden disorder improve quality life affect child family . Nutritional supplementation subcutaneous injection methyl B12 current treatment child autism anecdotal report remarkable clinical improvement side effect . However publish study support clinical benefit . Comparison : Injections methylcobalamin compare injection sterile saline six week period .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<criteria>Diagnosis DSM IV define autism meet cut Autism Diagnostic InventoryRevised ( ADIR ) Autism Diagnostic Observation Scale ( ADOS ) . Age 3 8 year IQ 50 Willingness parent administer subcutaneous methyl B12 . Parental agreement continue present dietary , behavioral psychotropic drug treatment change treatment 12 week intervention wait list . Clinical evidence seizure disorder Cancer Recent surgery Active infection fever Fragile X know genetic cause autism Bleeding disorder Perinatal brain injury ( e.g . cerebral palsy ) Current use methyl B12 product Evidence malnutrition see abnormal albumin level</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Autism</keyword>
	<keyword>Placebo</keyword>
	<keyword>B12</keyword>
	<keyword>Controlled</keyword>
	<keyword>Complementary Alternative Medicine</keyword>
	<keyword>Vitamin Supplement</keyword>
</DOC>